V503-004

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V503-004, covering 2019-11-21 to 2019-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004) [Phase 3]

See pricing